Defective peroxisome membrane synthesis due to mutations in human PEX3 causes Zellweger syndrome, complementation group G.
Zellweger cerebro-hepato-renal syndrome is a severe congenital disorder associated with defective peroxisomal biogenesis. At least 23 PEX genes have been reported to be essential for peroxisome biogenesis in various species, indicating the complexity of peroxisomal assembly. Cells from patients with peroxisomal biogenesis disorders have previously been shown to segregate into >/=12 complementation groups. Two patients assigned to complementation group G who had not been linked previously to a specific gene defect were confirmed as displaying a cellular phenotype characterized by a lack of even residual peroxisomal membrane structures. Here we demonstrate that this complementation group is associated with mutations in the PEX3 gene, encoding an integral peroxisomal membrane protein. Homozygous PEX3 mutations, each leading to C-terminal truncation of PEX3, were identified in the two patients, who both suffered from a severe Zellweger syndrome phenotype. One of the mutations involved a single-nucleotide insertion in exon 7, whereas the other was a single-nucleotide substitution eight nucleotides from the normal splice site in the 3' acceptor site of intron 10. Expression of wild-type PEX3 in the mutant cell lines restored peroxisomal biogenesis, whereas transfection of mutated PEX3 cDNA did not. This confirmed that the causative gene had been identified. The observation of peroxisomal formation in the absence of morphologically recognizable peroxisomal membranes challenges the theory that peroxisomes arise exclusively by growth and division from preexisting peroxisomes and establishes PEX3 as a key factor in early human peroxisome synthesis.
Muntau
A C
AC
Dr. von Hauner Children's Hospital, Laboratory of Molecular Biology, Ludwig-Maximilians-University, Munich, Germany.
Mayerhofer
P U
PU
Paton
B C
BC
Kammerer
S
S
Roscher
A A
AA
D000595:Amino Acid Sequence; D001483:Base Sequence; D002459:Cell Fusion; D004252:DNA Mutational Analysis; D005091:Exons / Q000235:genetics; D005347:Fibroblasts; D005455:Fluorescent Antibody Technique; D005816:Genetic Complementation Test; D006801:Humans; D006822:Hybrid Cells / Q000378:metabolism / Q000473:pathology; D007223:Infant; D007231:Infant, Newborn; D007425:Intracellular Membranes / Q000378:metabolism / Q000473:pathology*; D007438:Introns / Q000235:genetics; D008074:Lipoproteins / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D008297:Male; D008565:Membrane Proteins / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D009154:Mutation / Q000235:genetics*; D000074401:Peroxins; D020675:Peroxisomes / Q000378:metabolism / Q000473:pathology*; D011485:Protein Binding; D014162:Transfection; D015211:Zellweger Syndrome / Q000145:classification / Q000235:genetics* / Q000473:pathology* / Q000503:physiopathology
D008074:Lipoproteins; D008565:Membrane Proteins; D000074401:Peroxins; C113138:Pex3 protein, human